26,100 research outputs found

    Author Peter FitzSimons speaking at the National Library of Australia, Canberra, 13 November 2012 /

    No full text
    Title from acquisitions documentation.; Part of the collection: Portraits of author Peter FitzSimons speaking at the National Library of Australia, Canberra, 13 November 2012.; Acquired in digital format; access copy available online.; Mode of access: Online.; Photographed by a staff member of the National Library of Australia

    Editorial

    No full text

    Moral Good, the Beatific Vision, and God’s Kingdom Writings by Germain Grisez and Peter Ryan, S.J.. Edited by Peter J. Weigel

    No full text
    For close to half a century, the work of Germain Grisez has been highly influential, and his writings continue to receive considerable attention from philosophers and theologians of diverse viewpoints. His co-author for this work is the professor and noted moral theologian Fr. Peter Ryan, S.J., currently the executive director of the Secretariat of Doctrine and Canonical Affairs of the United States Conference of Catholic Bishops (USCCB). These two eminent scholars explore fundamental questions about Christian eschatology, moral theory, the purpose of human life, and the promise of human fulfilment. The authors examine Christian teaching on the final destiny of persons, investigating the meaning of God's kingdom, the hope of the beatific vision, and the centrality of moral goodness and divine grace in one's final end. This work is an ideal source for students, scholars, ministers and lay persons interested in basic questions of Christian theology, the philosophy of religion, ethical theory, and Catholic doctrin

    Murder on the mountain: author talk with Peter J. Wosh

    No full text
    Author talk by Peter J. Wosh on May 5th, 2022, on his book, "Murder on the Mountain: crime, passion, and punishment in gilded age New Jersey.

    Systemic sclerosis

    No full text
    Die Systemsklerose ist charakterisiert durch autoimmune Phänomene und eine progressive Fibrose. Klinische Charakteristika sind neben der Sklerodermie ein ausgeprägtes Raynaud-Phänomen und Abnormitäten der Nagelfalzkapillaren, ferner pulmonale, renale, kardiale und intestinale Veränderungen. In der Regel wird eine diffuse von einer limitierten Form unterschieden. Die diffuse Form führt zu einer Sklerose des gesamten Integumentes, ist assoziiert mit dem Auto-antikörper Scl-70 und zeichnet sich durch eine rasche Krankheitsprogression aus. Die limitierte Form betrifft die distalen Extremitäten und das Gesicht, ist assoziiert mit dem centromer Autoantikörper und führt schleichend, über mehrere Jahre zu viszeralen Problemen. Neue therapeutische Möglichkeiten können zu einer besseren Lebensqualität verhelfen und verpflichten zu einem systematischen Krankheitsmonitoring.Systemic sclerosis (scleroderma) is characterized by autoimmune phenomena and a progressive fibrosis. Clinical signs include Raynaud's phenomenon, pathognomonic nail fold capillary changes, pulmonal, renal, cardial and intestinal involvement. The two forms of systemic sclerosis, the diffuse and the limited show distinct disease phenomena and evolution. The diffuse form typically leads to a rapid sclerosis of the whole skin, it is associated with the auto-antibody Scl-70, it presents with an interstitial fibrosis of the lung, myositis and cardial fibrosis, a progressive loss of intestinal motility with maldigestion and it bears the risk of renal crisis. The limited form is characterized by sclerosis of the skin of the distal parts of the limbs and the face only, it is associated with the centromer auto-antibody and a much slower progression of visceral fibrosis. A typical late stage manifestation is pulmonary arterial hypertension. New drugs have improved quality of life. Their correct indication is based on a systematic monitoring of disease
    corecore